Stockscreener 앱 받기
16.04
0.50%
-0.08
시간 외 거래:
16.05
0.01
+0.06%
전일 마감가:
$16.12
열려 있는:
$16.12
하루 거래량:
4.85M
Relative Volume:
0.76
시가총액:
$10.95B
수익:
$125.68M
순이익/손실:
$4.81B
주가수익비율:
2.8389
EPS:
5.65
순현금흐름:
$-781.21M
1주 성능:
-0.80%
1개월 성능:
+16.49%
6개월 성능:
+66.22%
1년 성능:
+35.13%
1일 변동 폭
$15.90
$16.22
1주일 범위
$15.25
$16.79
52주 변동 폭
$8.73
$16.79
Roivant Sciences Ltd Stock (ROIV) Company Profile
명칭
Roivant Sciences Ltd
전화
441-295-5950
주소
7TH FLOOR, 50 BROADWAY, LONDON
ROIV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ROIV
Roivant Sciences Ltd
|
16.04 | 11.01B | 125.68M | 4.81B | -781.21M | 5.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-02 | 개시 | Citigroup | Buy |
| 2025-07-10 | 재개 | Goldman | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2024-01-05 | 개시 | Piper Sandler | Overweight |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-10-17 | 개시 | Guggenheim | Buy |
| 2023-06-08 | 개시 | BofA Securities | Neutral |
| 2022-10-27 | 개시 | JP Morgan | Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2022-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-12-15 | 개시 | Goldman | Buy |
| 2021-11-08 | 개시 | H.C. Wainwright | Buy |
| 2021-10-28 | 개시 | Citigroup | Buy |
| 2021-10-26 | 개시 | Cowen | Outperform |
| 2021-10-26 | 개시 | Jefferies | Buy |
| 2021-10-26 | 개시 | Truist | Buy |
모두보기
Roivant Sciences Ltd 주식(ROIV)의 최신 뉴스
How sentiment analysis helps forecast Roivant Sciences Ltd.July 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - newser.com
Is a relief rally coming for Roivant Sciences Ltd. holders2025 Bull vs Bear & Daily Oversold Bounce Ideas - newser.com
Combining machine learning predictions for Roivant Sciences Ltd.July 2025 Decliners & Reliable Volume Spike Trade Alerts - newser.com
Price action breakdown for Roivant Sciences Ltd.2025 Market Overview & Precise Swing Trade Entry Alerts - newser.com
Will earnings trigger a reversal in Roivant Sciences Ltd.Weekly Market Summary & Safe Entry Zone Identification - newser.com
Eric Venker Sells 355,161 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat
Eric Venker Sells 171,396 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat
Eric Venker Sells 138,602 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat
Using Bollinger Bands to evaluate Roivant Sciences Ltd.M&A Rumor & Safe Swing Trade Setups - newser.com
What earnings revisions data tells us about Roivant Sciences Ltd.Bear Alert & Comprehensive Market Scan Reports - newser.com
Is Roivant Sciences Ltd. (87S) stock undervalued historicallyPortfolio Risk Report & Real-Time Stock Entry Alerts - newser.com
Weiss Ratings Reaffirms "Sell (D+)" Rating for Roivant Sciences (NASDAQ:ROIV) - MarketBeat
Can Roivant Sciences Ltd. stock deliver consistent earnings growthPortfolio Value Report & Growth Focused Entry Reports - newser.com
What MACD and RSI say about Roivant Sciences Ltd.Market Growth Report & High Conviction Investment Ideas - newser.com
Roivant Sciences Hits New 52-Week High at $16.19, Up 52.84% - Markets Mojo
Roivant Sciences Hits New 52-Week High at $16.79, Surges 53.69% - Markets Mojo
Roivant Sciences’ president Venker sells $10.7m in shares - Investing.com
Valeo Financial Advisors LLC Buys Shares of 101,576 Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Rises on Nasdaq Composite with Strong Momentum - Kalkine Media
Roivant Sciences (NASDAQ:ROIV) Sets New 12-Month HighShould You Buy? - MarketBeat
Can you recover from losses in Roivant Sciences Ltd.2025 Price Action Summary & High Return Trade Guides - newser.com
What sentiment indicators say about Roivant Sciences Ltd. stockWeekly Trading Summary & Community Driven Trade Alerts - newser.com
Will Roivant Sciences Ltd. (87S) stock outperform value peersRisk Management & Consistent Profit Alerts - newser.com
Why Roivant Sciences (ROIV) Is Up 6.6% After Positive Phase 3 Brepocitinib Results and SEC Filing - simplywall.st
Why Roivant Sciences Ltd. (87S) stock attracts wealthy investorsTrade Risk Report & Fast Entry High Yield Stock Tips - newser.com
Will Roivant Sciences Ltd. continue its uptrendWeekly Investment Summary & Safe Capital Growth Tips - newser.com
Pattern recognition hints at Roivant Sciences Ltd. upsideMarket Growth Report & Safe Capital Growth Tips - newser.com
Why retail investors pile into Roivant Sciences Ltd. stock2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
Is Roivant Sciences Ltd. stock reversal real or fakeM&A Rumor & High Win Rate Trade Tips - newser.com
Can Roivant Sciences Ltd. (87S) stock double in coming yearsJuly 2025 Breakouts & Fast Entry Momentum Alerts - newser.com
Roivant’s Brepocitinib Phase 3 Dermatomyositis Trial Hits Primary and All Key Secondary Endpoints - Insider Monkey
Why Analysts Are Rethinking Roivant Sciences After Strong Phase 3 Results and Analyst Upgrades - Yahoo Finance
Elevate Capital Advisors LLC Sells 61,368 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (ROIV) files mixed shelf - StreetInsider
Roivant Sciences (ROIV): Assessing Valuation Following Positive Phase 3 Results and Analyst Optimism - simplywall.st
Roivant Sciences Ltd. $ROIV Shares Purchased by GAMMA Investing LLC - Defense World
Fifth Third Bancorp Sells 1,829 Shares of Roivant Sciences Ltd. $ROIV - Defense World
Long term hold vs stop loss in Roivant Sciences Ltd.July 2025 Closing Moves & High Return Stock Watch Alerts - newser.com
Roivant Sciences Ltd.’s volatility index tracking explainedWeekly Trend Recap & Expert Curated Trade Setup Alerts - newser.com
Roivant Sciences Ltd (ROIV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Roivant Sciences Ltd 주식 (ROIV) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Venker Eric | President & Immunovant CEO |
Oct 07 '25 |
Option Exercise |
7.21 |
355,161 |
2,559,093 |
1,860,120 |
| Venker Eric | President & Immunovant CEO |
Oct 06 '25 |
Option Exercise |
13.29 |
171,396 |
2,277,775 |
1,676,355 |
| Venker Eric | President & Immunovant CEO |
Oct 08 '25 |
Option Exercise |
8.07 |
138,602 |
1,119,164 |
1,643,561 |
| Venker Eric | President & Immunovant CEO |
Oct 07 '25 |
Sale |
16.15 |
355,161 |
5,735,850 |
1,504,959 |
| Venker Eric | President & Immunovant CEO |
Oct 06 '25 |
Sale |
16.34 |
171,396 |
2,800,611 |
1,504,959 |
| Venker Eric | President & Immunovant CEO |
Oct 08 '25 |
Sale |
16.20 |
138,602 |
2,245,352 |
1,504,959 |
5.74%
자본화:
|
볼륨(24시간):